UB Paderborn / Katalog / Suche / in CDI

1 – 24 von 24

Sortiert nach

De novo dominant variants affecting the motor domain of KIF1A are a cause of PEHO syndrome

European journal of human genetics : EJHG, 2016-06, Vol.24 (6), p.949-953

2016

Volltextzugriff (PDF)

CYP2D6 polymorphisms and codeine analgesia in postpartum pain management: a pilot study

Therapeutic drug monitoring, 2011-08, Vol.33 (4), p.425

2011

Volltextzugriff (PDF)

A novel recurrent mutation in ATP1A3 causes CAPOS syndrome

Orphanet journal of rare diseases, 2014-01, Vol.9 (1), p.15-15

2014

Volltextzugriff (PDF)

Systematic Critical Review of Genetic Factors Associated with Cisplatin-induced Ototoxicity: Canadian Pharmacogenomics Network for Drug Safety 2022 Update

Therapeutic drug monitoring, 2023-12, Vol.45 (6), p.714

2023

Volltextzugriff (PDF)

INTRAVENOUS N-ACETYLCYSTEINE TO PREVENT CISPLATIN-INDUCED HEARING LOSS IN CHILDREN: A NONRANDOMIZED CONTROLLED PHASE 1 TRIAL

Clinical cancer research, 2023-07, Vol.29 (13), p.2410-2418

2023

Volltextzugriff (PDF)

Role of Cisplatin Dose Intensity and TPMT Variation in the Development of Hearing Loss in Children

Therapeutic drug monitoring, 2023-06, Vol.45 (3), p.345

2023

Volltextzugriff (PDF)

Weaver Syndrome-Associated EZH2 Protein Variants Show Impaired Histone Methyltransferase Function In Vitro

Human mutation, 2016-03, Vol.37 (3), p.301-307

2016

Volltextzugriff (PDF)

Further Investigation of the Role of ACYP2 and WFS1 Pharmacogenomic Variants in the Development of Cisplatin-Induced Ototoxicity in Testicular Cancer Patients

Clinical cancer research, 2018-04, Vol.24 (8), p.1866-1871

2018

Volltextzugriff (PDF)

Common variation near IRF6 is associated with IFN-β-induced liver injury in multiple sclerosis

Nature genetics, 2018-08, Vol.50 (8), p.1081-1085

2018

Volltextzugriff (PDF)

Prevalence and risk factors for cisplatin-induced hearing loss in children, adolescents, and young adults: a multi-institutional North American cohort study

The lancet child & adolescent health, 2021-04, Vol.5 (4), p.274-283

2021

Volltextzugriff (PDF)

Reducing anthracycline-induced cardiotoxicity through pharmacogenetics

Pharmacogenomics, 2018-10, Vol.19 (15), p.1147-1150

2018

Volltextzugriff (PDF)

Integrating disease and drug-related phenotypes for improved identification of pharmacogenomic variants

Pharmacogenomics, 2021-04, Vol.22 (5), p.251-261

2021

Volltextzugriff (PDF)

Codeine-related deaths: The role of pharmacogenetics and drug interactions

Forensic science international, 2014-06, Vol.239, p.50-56

2014

Volltextzugriff (PDF)

Fatal hydrocodone overdose in a child: pharmacogenetics and drug interactions

Pediatrics (Evanston), 2010-10, Vol.126 (4), p.e986

2010

Volltextzugriff (PDF)

An investigation of morphine‐to‐codeine metabolic ratios in postmortem blood, drug interactions, and cytochrome P450 2D6 (CYP2D6) genotype

The FASEB journal, 2013-04, Vol.27 (S1)

2013

Volltextzugriff (PDF)

Output from the CIHR Canadian HIV Trials Network international postdoctoral fellowship for capacity building in HIV clinical trials

HIV/AIDS (Auckland), 2018-01, Vol.10, p.151-155

2018

Volltextzugriff (PDF)

Predicting Anthracycline‐induced Cardiotoxicity in Children – Genome‐Wide Association Study

The FASEB journal, 2013-04, Vol.27 (S1)

2013

Volltextzugriff (PDF)

Pharmacogenomics and active surveillance for serious adverse drug reactions in children

Pharmacogenomics, 2010-09, Vol.11 (9), p.1269-1285

2010

Volltextzugriff (PDF)

Apnea and Oxygen Desaturations in Children Treated with Opioids after Adenotonsillectomy for Obstructive Sleep Apnea Syndrome

Paediatric drugs, 2012-12, Vol.14 (6), p.411

2012

Volltextzugriff (PDF)

Genotypic Approaches to Therapy in Children

Annals of the New York Academy of Sciences, 2007-09, Vol.1110 (1), p.177-192

2007

Volltextzugriff (PDF)

Encapsulation of various recombinant mammalian cell types in different alginate microcapsules

Journal of biomedical materials research, 1998-12, Vol.42 (4), p.587-596

1998

Volltextzugriff (PDF)

A novel piezo-optical styrene sensor incorporating polymer-supported tribromide ion

Chemical communications (Cambridge, England), 2002-05 (9), p.980-981

2002

Volltextzugriff (PDF)

Parametric imaging of cerebral vascular reserve. 2. Reproducibility, response to CO2 and correlation with middle cerebral artery velocities

European Journal of Nuclear Medicine, 1991-04, Vol.18 (4), p.259

1991

Volltextzugriff (PDF)

The crystal structure of benzyltricarbonyl-η 5-cyclopentadienylmolybdenum(II) and related substituted benzyl complexes

Journal of organometallic chemistry, 1986-07, Vol.309 (1), p.117-123

1986

Volltextzugriff (PDF)

1 – 24 von 24

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(23)
Mit Volltextzugriff
(16)

Publikationsform

Artikel
(24)

Sprache

Englisch
(24)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

Science & Technology
(18)
Humans
(16)
Life Sciences & Biomedicine
(16)
Female
(8)
Adult
(7)
Child
(7)
Male
(7)
Pediatrics
(6)
Pharmacogenomics
(6)
Pharmacology & Pharmacy
(6)
Genomes
(5)
Patients
(5)
Antineoplastic Agents - Adverse Effects
(4)
Child, Preschool
(4)
Cisplatin - Adverse Effects
(4)
Genetics & Heredity
(4)
Genotype & Phenotype
(4)
Hearing Loss
(4)
Infant
(4)
Pharmacogenetics
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

De novo dominant variants affecting the motor domain of KIF1A are a cause of PEHO syndrome

CYP2D6 polymorphisms and codeine analgesia in postpartum pain management: a pilot study

A novel recurrent mutation in ATP1A3 causes CAPOS syndrome

Systematic Critical Review of Genetic Factors Associated with Cisplatin-induced Ototoxicity: Canadian Pharmacogenomics Network for Drug Safety 2022 Update

INTRAVENOUS N-ACETYLCYSTEINE TO PREVENT CISPLATIN-INDUCED HEARING LOSS IN CHILDREN: A NONRANDOMIZED CONTROLLED PHASE 1 TRIAL

Role of Cisplatin Dose Intensity and TPMT Variation in the Development of Hearing Loss in Children

Weaver Syndrome-Associated EZH2 Protein Variants Show Impaired Histone Methyltransferase Function In Vitro

Further Investigation of the Role of ACYP2 and WFS1 Pharmacogenomic Variants in the Development of Cisplatin-Induced Ototoxicity in Testicular Cancer Patients

Common variation near IRF6 is associated with IFN-β-induced liver injury in multiple sclerosis

Prevalence and risk factors for cisplatin-induced hearing loss in children, adolescents, and young adults: a multi-institutional North American cohort study

Reducing anthracycline-induced cardiotoxicity through pharmacogenetics

Integrating disease and drug-related phenotypes for improved identification of pharmacogenomic variants

Codeine-related deaths: The role of pharmacogenetics and drug interactions

Fatal hydrocodone overdose in a child: pharmacogenetics and drug interactions

An investigation of morphine‐to‐codeine metabolic ratios in postmortem blood, drug interactions, and cytochrome P450 2D6 (CYP2D6) genotype

Output from the CIHR Canadian HIV Trials Network international postdoctoral fellowship for capacity building in HIV clinical trials

Predicting Anthracycline‐induced Cardiotoxicity in Children – Genome‐Wide Association Study

Pharmacogenomics and active surveillance for serious adverse drug reactions in children

Apnea and Oxygen Desaturations in Children Treated with Opioids after Adenotonsillectomy for Obstructive Sleep Apnea Syndrome

Genotypic Approaches to Therapy in Children

Encapsulation of various recombinant mammalian cell types in different alginate microcapsules

A novel piezo-optical styrene sensor incorporating polymer-supported tribromide ion

Parametric imaging of cerebral vascular reserve. 2. Reproducibility, response to CO2 and correlation with middle cerebral artery velocities

The crystal structure of benzyltricarbonyl-η 5-cyclopentadienylmolybdenum(II) and related substituted benzyl complexes

Suchergebnisse filtern